Clinical Trials
🇺🇸 FDA Page 28FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 325–336 of 380 articles
Kyverna's Miv-cel Shows Breakthrough Results in Stiff Person Syndrome Trial, Potentially First Approved Treatment
InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial
Ractigen Therapeutics RAG-17 Shows 81% Reduction in ALS Biomarker in Phase I Trial
Mabwell's Nectin-4 ADC Bulumtatug Fuvedotin Shows Promise in Cervical Cancer Case Report Published in NEJM
Follicular Lymphoma Clinical Trials Surge: 45+ Companies Developing New Treatments in 2026
Obsidian Therapeutics OBX-115 Phase 2 Melanoma Data to Be Presented at ASCO 2026
Nuvalent to Present Pivotal Neladalkib Data from ALKOVE-1 Trial at ASCO 2026 for ALK-Positive Lung Cancer
Kenya Clinical Trial Guidelines: PPB's Research Site Certification Insights 2026
Clinical Trial Protocol Amendments: FDA Insights on Timeline & Cost Impact
FDA CID Pilot Program: Insights into Complex Innovative Trial Designs
Pasithea Therapeutics' PAS-004 Receives FDA Rare Pediatric Disease Designation for Neurofibromatosis Type 1 Treatment
Clearmind Medicine CMND-100 Meets Primary Safety Endpoint in Alcohol Use Disorder Trial